acids in the presence of terminal R,ꢀ-unsaturated alkynones
(Scheme 1).
Table 1. Optimization of Reaction Conditions of the Reaction
of 2,3-Allenoic Acid 1a and Alkynone 2aa
Scheme 1
yield of 3ab
yield of 4ab c
,
entry
2a (equiv)
solvent
1
2
3
4
5
6
7
8
9
1.1
1.1
1.1
1.1
1.1
1.1
1.5
1.1
1.1
DMSO
DMF
THF
dioxane
Et2O
Cl3CMe
Cl3CMe
Cl3CMe
Cl3CMe
33
6
0
30
59
59
55
71
71
70d
67e
19
17
25
12
12
11
14
Initially, we used 2-methyl-4-phenyl-2,3-butadienoic acid
1a and 1-phenyl-2-propyn-1-one 2a to try the reaction. To
our surprise, different from the reaction of 1a and methyl
propiolate,6b no 1:2 product 5a was afforded. Instead, a 1:1
adduct, i.e., an E/Z mixture of 4-(3′-oxo-1′-alkenyl)-2(5H)-
furanone product 4a referring to the noncyclic CdC bond,
was formed together with the cycloisomerization product 3a
under the catalysis of 5 mol % Pd(OAc)2 in the presence of
BF3·OEt2, and Sc(OTf)3 was not necessary. After screening
different reaction conditions, no better E/Z ratio for 4a was
observed, and in most cases the E/Z isomeric ratio changed
constantly, which indicated an E/Z isomerization. Some
typical results are listed in Table 1, from which we concluded
that Cl3CMe is better than other solvents, such as DMSO,
DMF, THF, dioxane, Et2O, in terms of the yields of 4a
(compare entries 1-5 with entry 6, Table 1) and the influence
of concentration of the substrates was negligible (compare
entry 9 with entry 6, Table 1). Increasing the amount of
alkynone 2a or BF3·Et2O also failed to improve the yields
(compare entries 7 and 8 with entry 6, Table 1).
a The reaction was carried out using 0.25 mmol of 1a, 1.1 equiv of 2a,
5 mol % of Pd(OAc)2, and 1.0 equiv of BF3·Et2O in 0.5 mL of solvent
with stirring overnight at 35 °C, unless other noticed. b Yields were
determined by 1H NMR analysis with CH2Br2 or mesitylene as the internal
standard. c The E/Z isomeric ratio of 4a changed constantly. d 1.5 equiv of
BF3·Et2O was used. e The concentration of 1a was 0.125 M.
E-isomer was investigated. After some screening, we were
happy to observe that after evaporation the addition of
DMSO followed by heating at 90 °C for 7 h afforded E-4a
(E/Z ) 99/1) in 70% NMR yield (Scheme 2). The structure
Scheme 2
With the observation that the E/Z-isomer of 4a is
interconvertable, a protocol for complete conversion of
the Z-isomer to the thermodynamically more stable
(5) (a) Ma, S.; Yu, Z. Org. Lett. 2003, 5, 1507. (b) Ma, S.; Yu, Z. Chem.
Eur. J. 2004, 10, 2078. (c) Ma, S.; Yu, Z.; Gu, Z. Chem. Eur. J. 2005, 11,
2351. (d) Ma, S.; Gu, Z.; Yu, Z. J. Org. Chem. 2005, 70, 6291. (e) Ma, S.;
Gu, Z. J. Am. Chem. Soc. 2005, 127, 6182. (f) Gu, Z.; Wang, X.; Shu, W.;
Ma, S. J. Am. Chem. Soc. 2007, 129, 10948. (g) Deng, Y.; Yu, Y.; Ma, S.
J. Org. Chem. 2008, 73, 585. (h) Deng, Y.; Li, J.; Ma, S. Chem. Eur. J.
2008, 14, 4263. (i) Hashmi, A. S. K. Angew. Chem., Int. Ed. Engl. 1995,
34, 1581. (j) Hashmi, A. S. K.; Ruppert, T. L.; Knofel, T.; Bats, J. W. J.
Org. Chem. 1997, 62, 7295. (k) Hashmi, A. S. K.; Schwarz, L.; Choi, J.-
H.; Frost, T. M. Angew. Chem., Int. Ed. 2000, 39, 2285. (l) Hashmi, A. S. K.;
Schwarz, L.; Bolte, M. Eur. J. Org. Chem. 2004, 1923. (m) Hashmi,
A. S. K.; Blanco, M. C.; Fischer, D.; Bats, J. W. Eur. J. Org. Chem. 2006,
1387. (n) Alcaide, B.; Almendros, P.; Martínez del Campo, T. Angew.
Chem., Int. Ed. 2006, 45, 4501. (o) Alcaide, B.; Almendros, P.; Martínez
del Campo, T. Eur. J. Org. Chem. 2007, 2844.
of E-4a was further confirmed by the X-ray diffraction
study (Figure 1).7
(8) Ma, S.; Wu, S. J. Org. Chem. 1999, 64, 9314.
(9) (a) Beck, B.; Magnin-Lachaux, M.; Herdtweck, E.; Domling, A. Org.
Lett. 2001, 3, 2875. (b) Marshall, J. A.; Piettre, A.; Paige, M. A.; Valeriote,
F. J. Org. Chem. 2003, 68, 1780. (c) Hegedus, L. S.; Geisler, L. J. Org.
Chem. 2000, 65, 4200. (d) Guo, Y.-W.; Gavagnin, M.; Mollo, E.; Trivellone,
E.; Cimino, G. J. Nat. Prod. 1999, 62, 1194. (e) de March, P.; Figueredo,
M.; Font, J.; Raya, J. Org. Lett. 2000, 2, 163. (f) Bagal, S. K.; Adlington,
R. M.; Baldwin, J. E.; Marquez, R. J. Org. Chem. 2004, 69, 9100. (g)
Kapferer, T.; Bruckner, R.; Herzig, A.; Konig, W. A. Chem. Eur. J. 2005,
11, 2154. (h) Vaz, B.; Dominguez, M.; Alvarez, R.; de Lera, A. R. J. Org.
Chem. 2006, 71, 5914. (i) Aurrecoechea, J. M.; Suero, R.; de Torres, E. J.
Org. Chem. 2006, 71, 8767.
(6) (a) Ma, S.; Gu, Z.; Deng, Y. Chem. Commun. 2006, 94. (b) Gu, Z.;
Ma, S. Angew. Chem., Int. Ed. 2006, 45, 6002. (c) Alcaide, B.; Almendros,
P.; Aragoncillo, C. Chem. Eur. J. 2002, 8, 1719.
(7) Crystal data for compound E-4a:C20H16O3, Mw ) 304.33, mono-
clinic, space group P2(1)/n, Mo KR, final R indices [I > 2σ(I)], R1 )
0.0349, wR2 ) 0.0940, a ) 11.5238 (3) Å, b ) 8.6194 (2) Å, c ) 16.6138
(5) Å, R ) 90°, ꢀ ) 102.1820 (10)°, γ ) 90°, V ) 1613.06 (7) Å3, T )
296 (2) K, Z ) 4, number of reflections collected/unique: 18026/2841 (Rint
) 0.0205), number of observations: 2841 [I > 2σ(I)], parameters 209.
CCDC 691718 contains the supplementary crystallographic data.
(10) (a) Boeckman, R. K., Jr.; Delton, M. H.; Nagasaka, T.; Watanabe,
T. J. Org. Chem. 1977, 42, 2946. (b) Kido, F.; Tsutsumi, K.; Maruta, R.;
Yoshikoshi, A. J. Am. Chem. Soc. 1979, 101, 6420. (c) Wu, T.-S.; Jong,
T.-T.; Ju, W.-M.; McPhail, A. T.; McPhail, D. R.; Lee, K.-H. J. Chem.
Soc., Chem. Commun. 1988, 14, 956. (d) Azuma, M.; Yoshida, M.;
Horinouchi, S.; Beppu, T. Biosci. Biotech. Biochem. 1993, 57, 344.
4236
Org. Lett., Vol. 10, No. 19, 2008